| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.49B | 37.43B | 29.68B | 25.43B | 22.07B | 18.49B |
| Gross Profit | 30.24B | 33.69B | 26.73B | 23.07B | 20.12B | 17.15B |
| EBITDA | 10.33B | 12.83B | 7.25B | 5.44B | 2.21B | 2.60B |
| Net Income | 5.33B | 7.03B | 3.56B | 2.49B | 66.00M | 551.00M |
Balance Sheet | ||||||
| Total Assets | 25.40B | 30.14B | 21.66B | 19.63B | 16.22B | 14.58B |
| Cash, Cash Equivalents and Short-Term Investments | 7.16B | 11.69B | 5.59B | 6.49B | 5.12B | 4.80B |
| Total Debt | 39.00M | 35.00M | 0.00 | 0.00 | 4.68B | 2.20B |
| Total Liabilities | 11.04B | 12.32B | 10.02B | 8.38B | 11.59B | 8.21B |
| Stockholders Equity | 14.30B | 17.81B | 11.63B | 11.25B | 4.63B | 6.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.80B | 2.91B | 2.28B | -1.53B | -811.00M |
| Operating Cash Flow | 0.00 | 10.68B | 5.60B | 4.55B | 1.33B | 472.00M |
| Investing Cash Flow | 0.00 | -3.10B | -3.09B | -2.53B | -3.12B | -1.49B |
| Financing Cash Flow | 0.00 | -1.39B | -3.60B | -777.00M | 1.93B | 1.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥6.53B | 21.40 | ― | 0.57% | 21.03% | 32.29% | |
70 Outperform | ¥90.70B | 18.51 | ― | 1.02% | 26.47% | 142.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥157.08B | 31.57 | ― | ― | 27.65% | 96.11% | |
60 Neutral | ¥6.74B | 27.15 | ― | ― | 11.32% | ― | |
55 Neutral | ¥116.90B | 293.64 | ― | ― | 31.57% | ― | |
52 Neutral | ¥200.20B | 143.78 | -19.16% | ― | 19.57% | -16.67% |